7 completed. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 3 |
Follow KHK7791: new trials by email Literature Review of KHK7791 trials Research Report on KHK7791
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis KHK7791 - Hyperphosphatemia | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 213 | 2021-03-15 | 2023-08-02 |
| Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis KHK7791, Placebo - Hyperphosphatemia | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 169 | 2021-03-15 | 2021-10-28 |
| Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis KHK7791, Placebo - Hyperphosphatemia | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 165 | 2021-03-08 | 2021-09-08 |
| Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis KHK7791 - Hyperphosphatemia | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 54 | 2021-03-03 | 2022-01-11 |
| Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients KHK7791, Placebp - Hyperphosphatemia | Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 47 | 2019-04-29 | 2024-03-07 |
| Dose-finding Study of KHK7791 in Hyperphosphatemia Patients KHK7791, Placebo - Hyperphosphatemia | Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 207 | 2019-04-15 | 2024-03-07 |
| A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD KHK7791 - Hyperphosphatemia | Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 67 | 2018-12-27 | 2024-03-07 |
Japan (7)